Provided by Tiger Trade Technology Pte. Ltd.

Caris Life Sciences, Inc.

28.24
-0.1100-0.39%
Volume:1.94M
Turnover:55.14M
Market Cap:7.97B
PE:75.91
High:28.97
Open:28.35
Low:28.07
Close:28.35
52wk High:33.66
52wk Low:14.19
Shares:282.15M
Float Shares:116.00M
Volume Ratio:0.62
T/O Rate:1.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3720
EPS(LYR):-3.2200
ROE:20.13%
ROA:8.77%
PB:13.47
PE(LYR):-8.77

Loading ...

Natera Q2 Revenue Rises Beats Estimates on Higher Overall Test Volumes, Raises 2026 Outlook

Reuters
·
Aug 07

Caris Life Sciences up over 15%, on Pace for Record Percent Increase

Dow Jones
·
Aug 06

Lantheus Q2 Revenue Rises 2.7%, Beats Estimates

Reuters
·
Aug 06

U.S. Research Roundup-Caterpillar, Eli Lilly, McKesson

Reuters
·
Aug 06

Sweden's Immunovia Q2 Sales Rise on PancreaSure Test Uptake

Reuters
·
Aug 06

Caris Life Sciences, Inc. : JP Morgan Cuts Targt Price to $25 from $30

THOMSON REUTERS
·
Aug 06

Caris Life Sciences, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Caris Life Sciences Q2 Revenue Rises 45% on the Back of Molecular Profiling Services

Reuters
·
Aug 06

Caris Life Sciences Q2 FY26 Net Loss Narrows to USD 0.6 Million; Revenue Rises 45% to USD 263.7 Million

Reuters
·
Aug 06

Caris Life Sciences Q2 Sales $263.712M Beat $238.125M Estimate

Benzinga Earnings
·
Aug 06

Caris Life Sciences Inc Q2 Net Loss Per Share $0.00

THOMSON REUTERS
·
Aug 06

Caris Life Sciences Inc Expected to Post Earnings of 1 Cent a Share - Earnings Preview

Reuters
·
Aug 04

Earning Preview: Caris Life Sciences, Inc. Q2 revenue is expected to increase by 74.08%, and institutional views are bullish

Earnings Agent
·
Jul 29

Analysts Offer Insights on NA Companies: Neptune Insurance Holdings, Inc. Class A (NP), Saizeriya Co (OtherSZYCF) and Caris Life Sciences, Inc. (CAI)

TIPRANKS
·
Jul 23

Caris Life Sciences Schedules Second-quarter 2026 Results Webcast

Reuters
·
Jul 16

CAI Corp calls August EGM to approve HK$0.33 share subscription by Longling Capital

TIPRANKS
·
Jul 16

Caris Life Sciences price target lowered to $30 from $31 at TD Cowen

TIPRANKS
·
Jul 15

CAI Corp Reports Unaudited Net Asset Value of HK$0.12 Per Share

TIPRANKS
·
Jul 15

CAI Corp Sets August Board Meeting to Approve Interim Results

TIPRANKS
·
Jul 15

Caris Life Sciences expands prostate cancer offering with PTEN IHC testing

TIPRANKS
·
Jul 14